Ulcerative colitis is a chronic, relapsing inflammatory condition of the gastrointestinal tract with a complex genetic and environmental etiology. In an effort to identify genetic variation underlying ulcerative colitis risk, we present two distinct genome-wide association studies of ulcerative colitis and their joint analysis with a previously published scan 1 , comprising, in aggregate, 2,693 individuals with ulcerative colitis and 6,791 control subjects. Fifty-nine SNPs from 14 independent loci attained an association significance of P < 10 −5 . Seven of these loci exceeded genome-wide significance (P < 5 × 10 −8 ). After testing an independent cohort of 2,009 cases of ulcerative colitis and 1,580 controls, we identified 13 loci that were significantly associated with ulcerative colitis (P < 5 × 10 −8 ), including the immunoglobulin receptor gene FCGR2A, 5p15, 2p16 and ORMDL3 (orosomucoid1-like 3). We confirmed association with 14 previously identified ulcerative colitis susceptibility loci, and an analysis of acknowledged Crohn's disease loci showed that roughly half of the known Crohn's disease associations are shared with ulcerative colitis. These data implicate approximately 30 loci in ulcerative colitis, thereby providing insight into disease pathogenesis.
l e t t e r s previously associated with ulcerative colitis included IL23R (ref. 3) , the HLA region (including the BTNL2 association) 1, 3, 8 , MST1 (ref. 9) , CARD9 (ref. 6 ), 1q32 (near IL10) 5 , 1p36 (RNF186-OTUD3-PLA2G2E) 1 , DLD-LAMB1 (ref. 1 ; also confirmed in a British ulcerative colitis GWA study 10 ), 12q15 (neighboring IFNG-IL26) 1 and 21q22 (ref. 11) . A second, back-up SNP was chosen for the six regions with P < 10 −6 in the discovery set. We chose additional SNPs (n = 4) from the 1p36, 2p16 and 12q15 regions because these SNPs seemed to be independently associated (r 2 < 0.2 in CEU HapMap). We also included ten SNPs with P values between 10 −4 and 10 −5 . Lastly, we included previously published associations with Crohn's disease and ulcerative colitis. These SNPs were typed in 2,009 individuals with ulcerative colitis and 1,580 control subjects of Dutch and Italian descent. (Complete data are given in Supplementary Table 1.) Overall, 13 loci achieved association with genome-wide statistical significance (P < 5 × 10 −8 ; Table 1 and Supplementary Table 2) . A fourteenth locus, containing the CARD9 gene, did not reach genome-wide significance but was significant after Bonferroni correction (P nominal = 5.48 × 10 −8 ; P corrected = 0.014). We achieved genome-wide significance for at least four loci new in populations of European origins, including 1q21 (FCGR2A-FCGR2C; this locus has been associated with ulcerative colitis in a Japanese population 12 ), 2p16 (REL-PUS10), 17q12 (ORMDL3) and 5p15 (rs4957048; ~30 kb from CEP72; Table 1 ). Fourteen loci that have been either suggested to be or conclusively associated with ulcerative colitis in previous studies, namely TNFSF15, NKX2-3, IL12B, MST1, IL18RAP, the HLA region, the IBD5 locus (5q31), RNF186-OTUD3-PLA2G2E, DLD-LAMB1, IL10, CARD9, 12q15 (IFNG-IL26), JAK2 and IL23R, were replicated in our study. We also showed an association with ten more loci previously associated with Crohn's disease or inflammatory bowel disease (IBD), namely IRGM, KIF21B, IKZF1, ICOSLG, CCL2-CCL7, 5p13 (near PTGER4), 21q21, CUL2-CREM, PSMG1 and STAT3 ( Table 2) . Replication of these previously identified ulcerative colitis, Crohn's disease or IBD loci was defined as an association at a level of P < 0.05 with the same risk allele identified in the index studies.
Two studies performed in populations of European descent identified further loci associated with IBD 10, 13 . We examined these loci within our discovery set (using the exact SNP or a perfect proxy, r 2 = 1.0) and found association between ulcerative colitis and 22q12 (an IBD-associated locus 13 ; P = 0.049), 16q22/CDH1 (an ulcerative colitis-associated locus 10 ; P = 0.0061) and the DLD-LAMB1 locus 10 discussed earlier. In addition, we found further evidence of association between the 1p36 locus (rs7524102, P = 0.0015), which showed strong (but not genome-wide significant) association in the WTCCC2 10 . We were not able to replicate the ulcerative colitis associations seen at 13q13 (P = 0.15), 20q13/HNF4A and 2q37/GPR35 (SNPs not in our data set and no proxy SNPs available) or the IBD associations seen at 16p11 (P = 0.17), 10q22/ZMIZ1 (P = 0.22) and 19q13 (SNP not in our data set and no proxy SNP available). Therefore, taking into account these additional associations, our analysis provides evidence for at least 30 distinct risk factors for ulcerative colitis. In three regions, 1p36 (RNF186-OTUD3-PLA2G2E), 2p16 (PUS10-REL) and 12q15 (IFNG-IL26), our scan identified several SNPs with P < 10 −5 that showed low linkage disequilibrium (LD) with each other l e t t e r s (r 2 < 0.2) in HapMap CEU samples. To determine whether several independent alleles were contributing at these loci, we performed conditional analyses in all scan and replication samples ( Table 3) . Although the signals for each SNP conditional on the other were greatly diminished in the 2p16 region (suggesting that these SNPs may both be in LD with a single, as yet unidentified, causal variant), we extended previous evidence for several independent associations at 1p36 and 12q15 (ref. 1). Particularly noteworthy are three SNPs at 1p36, each of which is genome-wide significant even while conditional on the other two. We also analyzed interaction between all pairs of SNPs listed in Table 1 . Among the 496 pairs of SNPs examined (Supplementary Table 3) , one pair (an interaction between SNPs at CARD9 and REL-PUS10) was significant after correction for the number of tests performed, and a second interaction at this locus approached significance after replication. Few such interactions have been documented in complex disease 14 , and further replication is warranted before this finding can be considered confirmed, but the known functional interaction between the CARD9 and REL proteins should not be overlooked.
It is clear from these ( Table 2 ) and other data that ulcerative colitis and Crohn's disease share some mechanistic pathways and susceptibility genes but that some pathways and genes are particular to each condition. We sought to estimate the proportion of alleles with an influence on both Crohn's disease and ulcerative colitis by calculating the likelihood of the observed ulcerative colitis genotype data at each Crohn's disease locus, under the alternative hypotheses that the ulcerative colitis sample has the same allele frequency as a Crohn's disease sample or that it has the same allele frequency as a control sample. The maximum data set likelihood was achieved when 15 or 16 of the Crohn's disease loci (essentially half of the 31) were presumed to affect risk for ulcerative colitis. This observation is consistent with the summarized results in Table 2 , where 14 of the 31 confirmed previous findings are significant at P < 0.01, three have 0.01 < P < 0.05 and the remainder fit the null distribution. The lack of complete overlap is unlikely to result entirely from limited power because our likelihood analysis limits the possibility that more than 20 of the Crohn's loci are shared, and some of the strongest Crohn's disease variants (for example, CARD15 and ATG16L1) are among the loci not associated with ulcerative colitis, despite the higher power to detect these variants of larger effect size.
All of the genes implicated by our work could plausibly have a functional role in ulcerative colitis (see Supplementary Table 4 for a summary of genes located near replicated ulcerative colitis risk SNPs not shared with Crohn's disease). A key next step in translating genetic loci to function requires that we understand gene function in the context of cell and tissue types relevant to human disease. Expression studies can help to identify relevant cell types for functional studies, the nature of which are likely to differ for genes expressed in epithelial cells, macrophages or lymphocytes. Here we focused on five ulcerative colitis susceptibility loci containing genes whose expression and function are not well established. We performed quantitative real-time PCR in human intestinal and immune cDNA samples (Supplementary Fig. 2a) .
The RNF186, PLA2G2E and OTUD3 genes are located at 1p36, which harbors two distinct ulcerative colitis risk SNPs (rs1317209 and rs6426833). Although RNF186 and OTUD3 are proteins with unknown function, both contain protein domains that have been associated with protein ubiquitination. This type of modification is known to regulate immune responses, as the OTU (ovarian tumor doma) protein TNFAIP3 has been identified as an important negative regulator of the transcription factor NF-κB 15 . Notably, the TNFAIP3 locus, which has been associated with several autoimmune conditions 16, 17 , is in the vicinity of one of the ulcerative colitis risk regions (rs2327832), although this locus achieved association at only a suggestive level of genome-wide significance (P = 3.92 × 10 −5 ). Expression of RNF186 was higher in intestinal tissues than in immune tissues. Immunostaining indicated that the RNF186 protein was expressed at the basal pole of epithelial cells and lamina propria within colonic tissues (Supplementary Fig. 2a,b) . By contrast, OTUD3 transcripts had higher levels in immune tissues (spleen, lymph nodes and peripheral blood mononuclear cells) and lymphocytes than in CD14-positive cells (data not shown). Phospholipase A2 group IIE (PLA2G2E) is a secretory PLA2 involved in the production of various types of proinflammatory lipid mediators 18 . PLA2G2E was undetectable in most tissues but showed weak expression in bone marrow, lymph node and thymus, suggesting that it has a role in immunity. Unexpectedly, we detected PLA2G2E very specifically in the small intestine but not in the colon. RNF186, OTUD3 and PLA2G2E showed very different expression patterns, suggesting that investigations of the biological functions of these candidate genes will require disparate strategies.
CEP72 and TPPP are located close to the ulcerative colitis risk SNP rs4957048. The CEP72 and TPPP proteins are both involved in microtubule organization and are expressed ubiquitously ( Supplementary  Fig. 2a,b) . LAMB1 and DLD are located near the ulcerative colitis risk SNPs rs4598195 and rs2237686 at 7q31 and are likewise expressed ubiquitously (Supplementary Fig. 2a) . LAMB1 is an extracellular matrix glycoprotein constituent of basement membranes. These data, together with reported associations between ulcerative colitis and CHD1 and CHD3 (ref. 10) , further implicate defects in barrier integrity in the development of colonic inflammation. 
e t t e r s
Future studies will need to integrate disease associations and the consequences of allele-specific expression to uncover the functional roles of genes in diseases such as ulcerative colitis. GSDMB and ORMDL3 are located near the ulcerative colitis risk SNPs rs2305480 and rs8067378. Both ORMDL3 and GSDMB showed higher expression in immune tissues as compared with intestinal tissues (Supplementary Fig. 2a) . We selected the ORMDL3 region for functional analysis not only because of the association with ulcerative colitis presented herein but also because ORMDL3 has been implicated in many diseases involving dysregulated immune responses, although the underlying mechanisms of this association remain unclear 2, [19] [20] [21] . The ORMDL3 protein is thought to be involved in protein folding, and growing evidence indicates that there are interactions between the unfolded protein response (UPR) and immune responses 22, 23 . We found that an ORMDL3-GFP fusion protein localized to the endoplasmic reticulum (ER; Fig. 1a) , confirming previous data 24 . We next investigated whether ORMDL3 expression is involved in the UPR in epithelial cells. Overexpression of ORMDL3 decreased both the basal and ER-stress-induced UPR (Fig. 1b) . Knockdown of ORMDL3 expression induced a higher UPR after tunicamycin or thapsigargin stimulation (Fig. 1c) , indicating that ORMDL3 expression levels can regulate UPR and that ORMDL3 might be an important factor in ensuring ER homeostasis.
This analysis increases our understanding of the pathogenesis of ulcerative colitis and its relationship to Crohn's disease, in addition to providing expression and functional data for some of the genes implicated. The genetic associations described here, together with other data 10, 12, 13 , highlight the importance of alterations in barrier function, cell-specific innate responses (ER stress, microbe-elicited responses, production of reactive oxygen species and activation of NF-κB), gene sets that coordinately regulate key functional programs in adaptive immunity and resolution of inflammation in the pathogenesis of ulcerative colitis. Taken together, our findings explain less than 10% of the variance of ulcerative colitis, and the challenge now is both to identify additional genetic factors and to translate these advances into real benefits for individuals with ulcerative colitis.
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Erratum: Genome-wide association identifies multiple ulcerative colitis susceptibility loci
